National Registry and Cohort Study of Pulmonary Vascular Disease
NCT ID: NCT05368467
Last Updated: 2025-06-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1000 participants
OBSERVATIONAL
2022-03-29
2028-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Pulmonary Hypertension Web-Based Health Care Program on Symptom Management, Social Support, Activity Tolerance, and Quality of Life in Patients With Pulmonary Hypertension.
NCT05908019
Safety Surveillance of Targeted Drugs for Pulmonary Hypertension Using a Computerized Follow-up System: a Nationwide Cohort Study
NCT05372263
Pulmonary Hypertension--Mechanisms and Family Registry
NCT00005357
rhBNP in Type 3 Pulmonary Hypertension
NCT05716984
the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension
NCT02061787
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
All consecutive consenting patients diagnosed with PH according to specific hemodynamic criteria at participating institutions.
The clinical course and disease management
The clinical course and disease management of pulmonary hypertension patients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
The clinical course and disease management
The clinical course and disease management of pulmonary hypertension patients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Documentation of mean pulmonary arterial pressure (mPAP) \>20 mm Hg by right heart catheterization, performed at any time prior to study enrollment.
Exclusion Criteria
* Do not meet the required hemodynamic criteria for entry into the study.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nanjing First Hospital, Nanjing Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shaoliang Chen, MD
Vice President of Nanjing First Hospital, Director of Cardiovascular Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Guangdong Provincial Peoples Hospital
Guangzhou, Guangdong, China
Nanjing First Hospital
Nanjing, Jiangsu, China
General Hospital of Tianjin Medical University
Tianjin, Tianjin Municipality, China
Beijing Anzhen Hospital of Capital Medical University
Beijing, , China
China-japan Friendship Hospital
Beijing, , China
Xiangya Second Hospital, Central South University
Changsha, , China
West China Hospital, Sichuan University
Chendu, , China
Nanjing Drum Tower Hospital
Nanjing, , China
General Hospital of Northen Theater of Command
Shenyang, , China
Tongji Hospital, Huazhong University of Science and Technology
Wuhan, , China
Zhongnan Hospital of Wuhan University
Wuhan, , China
First Affiliated Hospital of Xi'An Jiaotong University
Xi'an, , China
First Hospital of Zhengzhou University
Zhengzhou, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Caojing Zhang
Role: primary
Zhenweng Yang
Role: primary
Hong Gu
Role: primary
zhenguo zhai
Role: primary
Jiang, Li
Role: primary
Yucheng, Chen
Role: primary
Jiaxin Ye
Role: primary
Qiguang Wang
Role: primary
Xiaomei Guo
Role: primary
Gangcheng Zhang
Role: primary
Fenling Fan
Role: primary
Heping Gu
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NMU20220505
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.